BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23925446)

  • 1. Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Traversa D; Mazzi A; Di Cesare A; Famigli Bergamini P; Fracassi F; Fanini G; Aste G; Pampurini F; Boari A
    Parasitol Res; 2013 Nov; 112(11):3753-6. PubMed ID: 23925446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Giannelli A; Daugschies A; Dantas-Torres F; Otranto D
    Parasitol Res; 2013 Nov; 112(11):3979-80. PubMed ID: 24096604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprophylaxis of Dirofilaria immitis (Leidy 1856) infection at a high challenge environment.
    Labarthe NV; Willi LM; Paiva JP; Miranda MG; Zoreck K; Almeida FM
    Parasit Vectors; 2015 Oct; 8():523. PubMed ID: 26459036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heartworm control in Grenada, West Indies: Results of a field study using imidacloprid 10% + moxidectin 2.5% and doxycycline for naturally-acquired Dirofilaria immitis infections.
    Paterson T; Fernandez C; Burnett PJ; Lessey L; Hockley T; Hagen R; Coomansingh C; Sharma B; Chandrashekar R; Schaper R
    Vet Parasitol; 2020 Aug; 284():109194. PubMed ID: 32866837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
    Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
    Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
    Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
    Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
    Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
    Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
    Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a single administration of a spot-on solution containing imidacloprid 10%/moxidectin 2.5% in eliminating Dirofilaria repens microfilariae in naturally infected dogs.
    Traversa D; Aste G; Di Cesare A; Paoletti B; Di Tommaso M; Di Giulio E; Pampurini F; Tunesi C; Boari A
    Vet Parasitol; 2011 Jun; 179(1-3):107-12. PubMed ID: 21435791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs.
    McCall JW; Arther R; Davis W; Settje T
    Vet Parasitol; 2014 Nov; 206(1-2):86-92. PubMed ID: 25444277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate, Bayer) spot-on.
    Fok E; Jacsó O; Szebeni Z; Gyorffy A; Sükösd L; Lukács Z; Schaper R
    Parasitol Res; 2010 Apr; 106(5):1141-9. PubMed ID: 20165873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.
    Kryda K; Six RH; Walsh KF; Holzmer SJ; Chapin S; Mahabir SP; Myers M; Inskeep T; Rugg J; Cundiff B; Pullins A; Ulrich M; McCall JW; McTier TL; Maeder SJ
    Parasit Vectors; 2019 Sep; 12(1):445. PubMed ID: 31506094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric analyses of canine blood microfilariae isolated by the Knott's test enables Dirofilaria immitis and D. repens species-specific and Acanthocheilonema (syn. Dipetalonema) genus-specific diagnosis.
    Magnis J; Lorentz S; Guardone L; Grimm F; Magi M; Naucke TJ; Deplazes P
    Parasit Vectors; 2013 Feb; 6():48. PubMed ID: 23442771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.
    Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA
    Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field efficacy and safety of a combination of moxidectin and imidacloprid for the prevention of feline heartworm (Dirofilaria immitis) infection.
    Venco L; Mortarino M; Carro C; Genchi M; Pampurini F; Genchi C
    Vet Parasitol; 2008 Jun; 154(1-2):67-70. PubMed ID: 18395348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
    Hellmann K; Heine J; Braun G; Paran-Dobesova R; Svobodova V
    Parasitol Res; 2011 Aug; 109 Suppl 1():S77-86. PubMed ID: 21739377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    McTier TL; Six RH; Pullins A; Chapin S; Kryda K; Mahabir SP; Woods DJ; Maeder SJ
    Parasit Vectors; 2019 Sep; 12(1):444. PubMed ID: 31506088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
    Genchi M; Vismarra A; Lucchetti C; Viglietti A; Crosara S; Gnudi G; Quintavalla C; Schaper R; Kramer L
    Vet Parasitol; 2019 Sep; 273():11-16. PubMed ID: 31442887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.